- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05363995
Feasibility Trial i-Sleep & BioClock Intervention
Feasibility and Preliminary Effectiveness of a Blended E-health Intervention for Improving Sleep and the Biological Clock Among University Students (i-Sleep & BioClock)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Holland
-
Leiden, North Holland, Netherlands, 2333AK
- Leiden Univeristy
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Being fluent in Dutch and/or English
- Being enrolled as a student (Bachelor, Master or PhD) in one of the seven participating universities (Leiden University, Vrije Universiteit Amsterdam, Utrecht University, Maastricht University, Erasmus University Rotterdam, University of Amsterdam, Inholland University of Applied Sciences)
- Being ≥ 16 years old
- Having self-reported sleep problems; Insomnia Severity Index ≥ 8 (at least subthreshold insomnia)
Exclusion Criteria:
- Current risk for suicidal behaviour
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental
Blended e-health intervention
|
The 'i-Sleep & BioClock' intervention aims at improving sleep and the biological clock among university students. It is incorporates evidence-based techniques such as cognitive behavioural therapy for insomnia (CBTi). The intervention has a duration of 5 weeks and consists of five modules:
The intervention is supported by e-coaches who give personalized written feedback. Students will fill in a sleep & light exposure diary daily. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Insomnia Severity Index
Time Frame: Change from baseline (T0) to 7 weeks after baseline (T1)
|
7-item self-report instrument to assess insomnia severity, scores 0-28, higher scores indicating more insomnia severity
|
Change from baseline (T0) to 7 weeks after baseline (T1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sleep and light exposure diary
Time Frame: Change from week 0 (7 days prior to intervention period) to week 8 (7 days after T1)
|
This diary includes measures such as sleep efficiency, sleep onset latency, total sleep time, wake after sleep onset, number of awakenings, early morning awakening, time spent outside, screen use before bedtime)
|
Change from week 0 (7 days prior to intervention period) to week 8 (7 days after T1)
|
Munich Chronotype Questionnaire (MCTQ)
Time Frame: Change from baseline (T0) to 7 weeks after baseline (T1)
|
Self-rated scale to assess individual phase of entrainment on work and work-free days, Addresses questions about: bedtime, time spent in bed awake before deciding to turn off the lights, how long it takes to fall asleep, wake up time, get up time on work and work-free days.
MCTQ uses the midpoint between sleep on- and offset on free days (mid-sleep on free days, MSF) to assess chronotype
|
Change from baseline (T0) to 7 weeks after baseline (T1)
|
Patient Health Questionnaire (PHQ-9)
Time Frame: Change from baseline (T0) to 7 weeks after baseline (T1)
|
9-items self-report instrument for severity of depressive symptoms, scores ranging from 0-27, higher scores indicating more severe depression
|
Change from baseline (T0) to 7 weeks after baseline (T1)
|
Generalised Anxiety Disorder scale (GAD-7)
Time Frame: Change from baseline (T0) to 7 weeks after baseline (T1)
|
7-items self-report instrument for severity of anxiety symptoms, scores ranging from 0-21, higher scores indicating more severe anxiety
|
Change from baseline (T0) to 7 weeks after baseline (T1)
|
Work and Social Adjustment Scale (WSAS)
Time Frame: Change from baseline (T0) to 7 weeks after baseline (T1)
|
5-item self-report instrument for impairment of functioning, scores ranging from 0-40, higher scores indicating more impairment in functioning
|
Change from baseline (T0) to 7 weeks after baseline (T1)
|
Mental Health Quality of Life questionnaire (MHQoL)
Time Frame: Change from baseline (T0) to 7 weeks after baseline (T1)
|
7-item self report instrument for quality of life measure for use in people with mental health problems, scores ranging from 0-21, higher scores indicating higher quality of life, and MHQoL-VAS visual scale ranging from 0 (worst imaginable psychological wellbeing) to 10 (best imaginable psychological wellbeing)
|
Change from baseline (T0) to 7 weeks after baseline (T1)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Client Satisfaction Questionnaire (CSQ-8)
Time Frame: 7 weeks after baseline (T1)
|
8-item self-report questionnaire for client satisfaction with services, total score ranging from 8-32, higher indicating higher satisfaction
|
7 weeks after baseline (T1)
|
System Usability Scale (SUS-10)
Time Frame: 7 weeks after baseline (T1)
|
10-item self-report scale for system usability, five response options for respondents; from strongly agree to strongly disagree, scores ranging from 0-40, higher scores indicating better system usability
|
7 weeks after baseline (T1)
|
Working Alliance Inventory for guided Internet interventions (WAI-I)
Time Frame: 7 weeks after baseline (T1)
|
12-item self-report instrument to capture alliance in guided Internet interventions, 5-point Likert scale ranging from 1 (never) to 5 (always), scores ranging from 12-60, higher scores indicating better alliance
|
7 weeks after baseline (T1)
|
Acceptability and usability of the sleep & light exposure diary
Time Frame: 7 weeks after baseline (T1)
|
11 items on the sleep & light exposure diary, 5 point Likert Scale, scores ranging from 0-44, higher scores indicating better usability and acceptability, one visual scale on usefulness of the diary, 0 (not at all useful) to 10 (Very much useful)
|
7 weeks after baseline (T1)
|
Adherence to the program
Time Frame: Through study completion, on average 7 weeks
|
Will be measured by the total number of completed modules and lessons, time spent in the platform, and the number of logins
|
Through study completion, on average 7 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Niki Antypa, PhD, Leiden University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- BioClockWP1.4
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insomnia
-
National Science Council, TaiwanCompleted
-
Sunshine Lake Pharma Co., Ltd.Unknown
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
Massachusetts General HospitalNational Institutes of Health (NIH)Completed
-
IpsenCompletedThe Effectiveness of Circadin in Improving Quality of Sleep in Patients Aged 55 or Over (QUALISLEEP)InsomniaRussian Federation
-
Charite University, Berlin, GermanyCompleted
-
Roxane LaboratoriesCompleted
-
Butler HospitalSunovionCompleted
-
Merck Sharp & Dohme LLCCompleted
Clinical Trials on i-Sleep & BioClock Intervention
-
Stanford UniversityVA Palo Alto Health Care SystemCompletedDepression | Insomnia | Suicidal IdeationUnited States
-
Leiden University Medical CenterNot yet recruiting
-
University of California, BerkeleyEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedSleep Deprivation | Adolescent BehaviorUnited States
-
Central South UniversityUnknown
-
Wayne State UniversityNational Heart, Lung, and Blood Institute (NHLBI)RecruitingHypertension | Sleep | Sleep Apnea | Insufficient Sleep SyndromeUnited States
-
University of California, Los AngelesVA Office of Research and DevelopmentRecruitingCardiovascular Diseases | Insomnia | Posttraumatic Stress Disorder | Metabolic DiseaseUnited States
-
Karolinska InstitutetCompleted
-
University of ChicagoCompletedChronic Kidney DiseaseUnited States
-
Brigham and Women's HospitalCompletedBurnout, Professional | Stress, Psychological | Insomnia | Anxiety | Sleep DisturbanceUnited States
-
Big Health Inc.University of California, San FranciscoCompleted